4//SEC Filing
Malamut Richard 4
Accession 0001192482-21-000088
CIK 0001267565other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:32 PM ET
Size
9.1 KB
Accession
0001192482-21-000088
Insider Transaction Report
Form 4
Malamut Richard
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2021-01-19+36,960→ 96,790 total - Award
Stock Option (Right to Purchase)
2021-01-19+105,600→ 105,600 totalExercise: $24.06Exp: 2031-01-19→ Common Stock (105,600 underlying) - Award
Common Stock
2021-01-19+2,187→ 98,977 total
Footnotes (3)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
- [F2]On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 2,187 performance share units granted in a prior year.
- [F3]Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.
Documents
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001772168
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:32 PM ET
- Size
- 9.1 KB